---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-158442"
form_type: "8-K"
ticker: "ZBH"
cik: "0001136869"
company_name: "ZIMMER BIOMET HOLDINGS, INC."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:36:44.227242+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Zimmer Biomet to acquire Monogram Technologies for ~$177M upfront plus CVR up to $12.37/share

## Summary
- Equity value ~$177M ($4.04/share cash upfront); enterprise value ~$168M.
- Common stockholders receive non-tradeable CVR up to $12.37/share if product, regulatory and revenue milestones through 2030 are met.
- Acquisition neutral to adjusted EPS in 2025-2027, accretive in 2028+; expected to contribute to revenue growth beginning 2027.
- Monogram's semi-autonomous TKA robot (FDA 510(k) March 2025) and fully autonomous system in development will expand Zimmer Biomet's ROSA robotics platform.
- Closing expected later this year, subject to Monogram stockholder approval, regulatory clearances and other customary conditions.

## SEC filing metadata
- accession: 0001193125-25-158442
- form_type: 8-K
- ticker: ZBH
- cik: 0001136869
- company_name: ZIMMER BIOMET HOLDINGS, INC.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1136869/000119312525158442/0001193125-25-158442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1136869/000119312525158442/d76564d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-158442
- JSON: https://secwatch.observer/filing/0001193125-25-158442.json
- Plain text: https://secwatch.observer/filing/0001193125-25-158442.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.